BBK Worldwide Blog

In the September issue of PM360, Rob Laurens joins other industry thought leaders to share their opinions on what it takes today for life sciences companies to practice a patient-first approach.

According to the Centers for Disease Control and Prevention (CDC), among the top ten leading causes of death in the United States per year are diseases that include heart disease (696,962), cancer (602,350), stroke (160,264), Alzheimer’s disease (134,242) and diabetes (102,188).¹ It makes sense, then, that there would be substantial clinical efforts to provide preventative and curative treatments for these conditions. However, when planning your trial to test the efficacy of your treatment, how often do you reflect on the actual patient population?

BBK's patient recruitment campaign for Parkinson's disease has been selected as a finalist for the Pharmaceutical Executive APEX Awards

It's exciting times here at BBK! We are so thrilled to be recognized for our creative work on the Cerevel TemPo Studies website; developed to inform and prescreen patients newly diagnosed with Parkinson’s disease. We've been selected as a finalist for this year’s Pharmaceutical Executive APEX Awards — the only healthcare marketing awards judged entirely by HCPs. 

The Impact of the EU Clinical Trials Regulation on Patient Recruitment Planning

The EU Clinical Trials Regulation (CTR) replaces the Clinical Trials Directive 2001 / 20 / EC and looks to ensure a unified set of rules for the conduct of clinical trials throughout the European Union. From the outset, policymakers had the aim of making the EU more attractive to clinical trials by simplifying submissions, authorizations and conduct among EU member states, thereby also offering greater transparency into trial data.

Catch Up on Our Content for Clinical Trial Sponsors

Featuring insights from industry thought leaders, our content provides clinical trial sponsors with knowledge and guidance to help navigate today’s challenging clinical trial patient recruitment and engagement environment.

Hear From Our Experts on Improving Clinical Trial Enrollment Diversity

In our latest podcast, BBK's Justin Jones and Gaby Grekin discuss strategies and insights that clinical trial sponsors can leverage to make their studies more diverse and inclusive.  

Introducing a New Approach to Clinical Trial Recruitment & Engagement

Our hybrid approach to clinical trial recruitment and engagement provides sponsors with the flexibility and agility they need whether they are conducting a traditional site-based trial, hybrid trial, or decentralized trial. 

Pharma15 Live!

Facilitating the Journey from Patient to Study Participant

The Impact of Dynamic Referral Processing

Matt Kibby and Aaron Fleishman return to the Pharma15 Live! stage to discuss BBK's dynamic referral processing service and how it improves and accelerates the patient enrollment process. 

"Our process benefits both patients and sites alike. It unburdens the study staff, creating a better experience for them, while also ensuring patients are responded to more quickly and with better care so their journey is a positive one."

-Matt Kibby, President, Chief Strategy Officer, BBK Worldwide

Blueprint for Success: Proven Strategies for Patient Engagement

Download our blueprint for patient engagement and get a compilation of ideas and proven strategies to help you and your clinical trial team create a successful patient engagement program.

Words Matter: The Hybrid Lexicon

In a time of confusing terminology, one thing is clear: what the industry used to consider exceptional is now considered essential.

Hybrid. Decentralized. Remote. Digital. Virtual. Companies use these terms interchangeably. There is inconsistency, over-hyping, over-promising, confusion and a notable lack of substance. To be honest, it’s a bit like the Wild West out there.